FLEMINGTON, N.J., March 19, 2013 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCBB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that the company has engaged The Ruth Group as its public relations and investor relations agency of record.
